-+ 0.00%
-+ 0.00%
-+ 0.00%

*Oragenics: Received Responses From FDA Related to Its Type B Meeting Request Briefing Package, Submitted in July >OGEN

Dow Jones·08/28/2026 20:31:00

Please log in to view news